The Patent Finder

4 Aza Bioscience N.V.

Also on record
Records under this name other than patents 4 Aza Bioscience N.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 5 of 5 · Back to 4 Aza Bioscience N.V.

PatentTitleStatus Expires Confidence
US 7,501,513Immunosuppressive effects of pteridine derivatives
Lapsed on the fee record
Ended Mar 10, 2013 · From the USPTO record
Lapsed on the fee recordEnded Mar 10, 2013From the USPTO record
US 7,276,506Immunosuppressive effects of pteridine derivatives
Lapsed on the fee record
Ended Oct 2, 2011 · From the USPTO record
Lapsed on the fee recordEnded Oct 2, 2011From the USPTO record
US 6,432,968Combination preparation, containing cyclosporin a or FK506 or rapamycin and a xanthine derivative
Lapsed on the fee record
Ended Aug 13, 2010 · From the USPTO record
Lapsed on the fee recordEnded Aug 13, 2010From the USPTO record
US 6,946,465Immunosuppressive effects of pteridine derivatives
Lapsed on the fee record
Ended Sep 20, 2009 · From the USPTO record
Lapsed on the fee recordEnded Sep 20, 2009From the USPTO record
US 6,046,328Combination preparation, containing cyclosporin A or FK506 or rapamycin and a xanthine derivative
Lapsed on the fee record
Ended Apr 4, 2008 · From the USPTO record
Lapsed on the fee recordEnded Apr 4, 2008From the USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited